Kardiyak Hastalığa Sahip Gebelerde Doğum Yaklaşımları; Normal Doğum Mu? Sezaryen Mi?
Özet
Gebelik, doğum eylemi ve doğum sonrası dönemde maternal ile fetal morbidite ve mortalitenin önemli nedenlerinden biri olan kalp hastalıkları; kan hacmi, kalp atım hızı ve kardiyak debi artışı gibi fizyolojik değişimler sebebiyle kalbin iş yükünü artırarak dekompanzasyona yol açabilir. Uterin kontraksiyonlar sonucu gerçekleşen ototransfüzyon, sempatik aktivasyon ve ıkınma eylemi hemodinamik yükü ve kardiyak outputu belirgin şekilde yükseltir. Kalp hastası gebelerin yönetiminde temel amaç en az riskli doğum şeklini belirlemektir. Vajinal doğum; kan kaybı, enfeksiyon, venöz tromboz ve tromboemboli riskini azaltması ve erken mobilizasyon sağlaması nedeniyle öncelikli tercihtir. Sezaryen doğum ise obstetrik gerekliliklerin yanı sıra Eisenmenger sendromu, pulmoner hipertansiyon, aşırı aort stenozu, akut inatçı kalp yetmezliği veya oral antikoagülan alanlarda fetal intrakranial kanama riskini önlemek için uygulanır. Vajinal doğum indüksiyonunda oksitosin ile prostaglandinler kullanılabilir ve kardiyak yükü azaltmak amacıyla epidural anestezi ile asiste (vakum/forseps) doğum önerilir. Postpartum ilk 24-48 saat ani hemodinamik değişimler nedeniyle kalp yetmezliği riski taşıdığından hastalar yakın takip edilmelidir. Antikoagülan tedavide unfraksiyone heparin ve düşük molekül ağırlıklı heparin güvenle kullanılırken, warfarin teratojenik etkileri nedeniyle sınırlı durumlar dışında tercih edilmemelidir. Rutin enfektif endokardit profilaksisi önerilmeyip yalnızca protez kapak veya geçirilmiş endokardit öyküsü gibi yüksek riskli gebelere uygulanmalıdır.
Referanslar
Luthra A, Bajaj R, Jafra A, et al. Anesthesia in pregnancy with heart disease. Saudi journal of anaesthesia, 2017;11(4):454.
Fraccaro C, Tence N, Masiero G, Karam N. Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment. Interventional Cardiology Review, 2020;15. Published online 2020 Jul 29. doi: 10.15420/icr.2020.06
Endorsed by the European Society of Gynecology tAfEPC, Medicine tGSfG, Members ATF, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). European heart journal, 2011;32(24):3147-97.
Jason SC, Karen S, Easterlıng T. Heart Disease in Pregnancy. Gabbe Obsterics Normal and Problem Pregnancies Seventh Edition.1 (Section VI Pregnancy and Coexisting Disease):803-27.
Driul L, Meroi F, Sala A, et al. Vaginal delivery in a patient with severe aortic stenosis under epidural analgesia, a case report. Cardiovascular Ultrasound, 2020;18(1):1-8. doi: 10.1186/s12947-020-00226-x
Kampman MA, Balci A, Veldhuisen DJ, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. European heart journal, 2014;35(11):708-15. doi: 10.1093/eurheartj/eht526
Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart, 2016;102(7):518-26. doi.org/10.1136/heartjnl-2015-308476
Almeida F, Pavan M, Rodrigues C. The haemodynamic, renal excretory and hormonal changes induced by resting in the left lateral position in normal pregnant women during late gestation. BJOG: An International Journal of Obstetrics & Gynaecology, 2009;116(13):1749-54. doi:10.1111/j.1471-0528.2009.02353.x
Tanaka H, Kamiya C, Katsuragi S, et al. Effect of epidural anesthesia in labor; pregnancy with cardiovascular disease. Taiwanese Journal of Obstetrics and Gynecology, 2018;57(2):190-3. doi.org/10.1016/j.tjog.2018.02.004
Dogra Y, Suri V, Aggarwal N, Dogra RK. Induction of labor with oxytocin in pregnancy with low-risk heart disease: A randomized controlled trial. Turkish journal of obstetrics and gynecology, 2019;16(4):213.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC), European heart journal. 2018;39(34):3165-241.
Hamm RF, Srinivas SK, Levine LD. A standardized labor induction protocol: impact on racial disparities in obstetrical outcomes. American journal of obstetrics & gynecology MFM, 2020;2(3):100148. Doi: 10.1016/j.ajogmf.2020.100148
Lim G, Facco FL, Nathan N, et al. A review of the impact of obstetric anesthesia on maternal and neonatal outcomes. Anesthesiology, 2018;129(1):192-215. doi: 10.1097/ALN.0000000000002182
Vaan MD, Ten Eikelder ML, Jozwiak M, W, et al. Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews, 2019(10).
Secher N, Thayssen P, Arnsbo P, Olsen J. Effect of prostaglandin E2 and F2α on the systemic and pulmonary circulation in pregnant anesthetized women. Acta obstetricia et gynecologica Scandinavica. 1982;61(3):213-8.
Alfirevic Z, Gyte GM, Pileggi VN, Plachcinski R, Osoti AO, Finucane EM. Home versus inpatient induction of labour for improving birth outcomes. Cochrane Database of Systematic Reviews, 2020(8).
Kim GS, Yang M, Chang CH, et al. Management of cardiac arrest in a parturient with Eisenmenger's syndrome and complete atrioventricular block during Cesarean section: a case report. Korean journal of anesthesiology. 2015;68(6):617.
Pediatrics AA. American College of Obstetricians and Gynecologists Fetal heart rate monitoring. Guidelines for perinatal care 7th ed Washington, DC: American College of Obstetricians and Gynecologists, 2012.
Kela M, Buddhi M. Combined mitral and aortic stenosis in parturient: Anesthesia management for labor and delivery. Journal of anaesthesiology, clinical pharmacology, 2017;33(1):114.
Hofmeyr GJ, Gülmezoglu AM, Novikova N, et al. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bulletin of the World Health Organization, 2009;87:666-77.
Svanström M, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. British journal of anaesthesia, 2008;100(5):683-9.
Cauldwell M, Steer PJ, Swan L, Uebing A, Gatzoulis MA, Johnson MR. The management of the third stage of labour in women with heart disease. Heart, 2017;103(12):945-51. doi:10.1093/bja/aen071
Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics, 2016;138(3).
Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart. 2014;100(3):231-8.
Elkayam U, Goland S, Pieper PG, et al. High-risk cardiac disease in pregnancy: part I. Journal of the American College of Cardiology, 2016;68(4):396-410.
Lu E, Shatzel JJ, Salati J, et al. The safety of low-molecular-weight heparin during and after pregnancy. Obstetrical & gynecological survey, 2017;72(12):721-9. doi: 10.1097/OGX.0000000000000505
Jacobson B, Rambiritch V, Paek D, et al. Safety and efficacy of enoxaparin in pregnancy: a systematic review and meta-analysis. Advances in therapy, 2020;37(1):27-40.
Sousa AR, Barreira R, Santos E. Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome. Case Reports, 2018; 2018: bcr2017223159. Published online 2018 Apr 7. doi: 10.1136/bcr-2017-223159
Wainwright H, Beighton P. Warfarin embryopathy: fetal manifestations. Virchows Archiv, 2010; 457:735–739. Doi: 10.1007/s00428-010-0982-9
Cotrufo M, De Feo M, De Santo LS, et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstetrics and Gynecology, 2002;99(1):35-40.
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy, Blood advances, 2018;2(22):3317-59. doi: 10.1182/bloodadvances.2018024802
Skeith L. Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold. Hematology 2014, the American Society of Hematology Education Program Book, 2017;2017(1):160-7.
Chai-Adisaksopha C, Hillis C, Siegal DM, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thrombosis and haemostasis, 2016;116(11):879-90.
Şimşek-Yavuz S, Akar AR, Aydoğdu S, et al. Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group. Turkish Journal of Thoracic and Cardiovascular Surgery, 2020;28(1):2.
Quan TP, Muller-Pebody B, Fawcett N, et al. Investigation of the impact of the NICE guidelines regarding antibiotic prophylaxis during invasive dental procedures on the incidence of infective endocarditis in England: an electronic health records study. BMC medicine, 2020;18:1-17.
Yeler D, Nihat Ç, Yeler H. Diş hekimliğinde enfektif endokardit riski ve profilaksi gerekliliği. Cumhuriyet Dental Journal, 2011;14(2):133-9.